NextCure, Inc. (NXTC) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Join SI Premium – FREE
NextCure, Inc. (NASDAQ: NXTC) reported Q1 EPS of ($0.61), $0.17 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Raises S&P500 Target to 8,100
- Merck (MRK) PT Raised to $170 at Guggenheim
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
